(Q45353475)

13 December 2017

B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis (English)

1 reference

secondary progressive multiple sclerosis

13 December 2017

0 references

0 references

0 references

5

1 reference

13 December 2017

Barbara Rosicarelli

3

0 references

Francesca Aloisi

object named as

Francesca Aloisi

7

0 references

author name string

Roberta Magliozzi

1

1 reference

13 December 2017

Barbara Serafini

2

1 reference

13 December 2017

Giuseppe Chiappetta

4

1 reference

13 December 2017

Richard Reynolds

6

1 reference

13 December 2017

1 January 2013

1 reference

Journal of Neuropathology & Experimental Neurology

13 December 2017

1 reference

13 December 2017

72

1 reference

13 December 2017

1

1 reference

13 December 2017

29-41

1 reference

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

13 December 2017

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Cortical lesions in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Gray matter pathology in (chronic) MS: modern views on an early observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

The immunopathology of multiple sclerosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Inflammatory cortical demyelination in early multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

The neuropathological basis of clinical progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Cortical blood vessels of the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

The BFRF1 gene of Epstein-Barr virus encodes a novel protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Lymphoid neogenesis in chronic inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

A clear case of possession. Editorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

B cells and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

The evidence for a role of B cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Epstein-barr virus infection and multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

An attempt to investigate the presence of Epstein Barr virus in multiple sclerosis and normal control brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827BFC62

10.1097/NEN.0B013E31827BFC62

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference